

| Каталожный номер | AF004193 | ||||
|---|---|---|---|---|---|
| Описание |
Anti-Matuzumab Non-Neutralizing Recombinant Antibody (SAA3027) (AF004193) is a mouse monoclonal antibody detecting EGFR in ELISA. Suitable for General.
Highlights
|
||||
| Реактивность видов | General | ||||
| Применения | ELISA | ||||
| Хозяинский вид | Mouse | ||||
| Клоональность | Monoclonal | ||||
| Изотип | IgG1, kappa | ||||
| ID клона | SAA3027 | ||||
| Система экспрессии | Mammalian cells | ||||
| Иммуноген | Matuzumab | ||||
| Цель | IgG1 | ||||
| Уровень эндотоксинов | < 10 EU/mg as determined by LAL method. | ||||
| Чистота | >95% as determined by SDS-PAGE. | ||||
| Очистка | Protein A/G purified from cell culture supernatant. | ||||
| Номер доступа | CAS: 339186-68-4 | ||||
| Форма | Liquid | ||||
| Буфер хранения | 0.01M PBS pH 7.4. Пожалуйста, обратитесь к конкретной информации о буфере в печатной версии даташита или в индивидуальном сертификате качества (COA) для партии. |
||||
| Информация об использовании продукта |
| ||||
| Устойчивость и хранение | Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt. | ||||
| Фон | Epidermal growth factor receptor (EGFR/ERBB1) is a ~134 kDa protein. Receptor tyrosine kinase binding ligands of the EGF family and activating several signaling cascades to convert extracellular cues into appropriate cellular responses. Known ligands include EGF, TGFA/TGF-alpha, AREG, epigen/EPGN, BTC/betacellulin, epiregulin/EREG and HBEGF/heparin-binding EGF. Ligand binding triggers receptor homo- and/or heterodimerization and autophosphorylation on key cytoplasmic residues. The phosphorylated receptor recruits adapter proteins like GRB2 which in turn activates complex downstream signaling cascades. Activates at least 4 major downstream signaling cascades including the RAS-RAF-MEK-ERK, PI3 kinase-AKT, PLCgamma-PKC and STATs modules. EGFR is the therapeutic target of cetuximab (Erbitux) and panitumumab (Vectibix). _x005F_x000D_ _x005F_x000D_1. Arcaro, A. et al. (2000) Molecular and cellular biology 20, 3817-30. PMID: 10805725 _x005F_x000D_
_x005F_x000D_
2. Runkle, KB. et al. (2016) Molecular cell 62, 385-396. PMID: 27153536 _x005F_x000D_
_x005F_x000D_
3. Chen, WS. et al. (1989) Cell 59, 33-43. PMID: 2790960 _x005F_x000D_
_x005F_x000D_
4. Bu, J. et al. (2022) Acta biochimica et biophysica Sinica 54, 400-408. PMID: 35538033 _x005F_x000D_
_x005F_x000D_
5. Garrett, TP. et al. (2002) Cell 110, 763-73. PMID: 12297049 _x005F_x000D_
_x005F_x000D_
6. Kochupurakkal, BS. et al. (2005) The Journal of biological chemistry 280, 8503-12. PMID: 15611079 _x005F_x000D_
_x005F_x000D_
7. Kim, J. et al. (2007) Cancer research 67, 9229-37. PMID: 17909029 _x005F_x000D_
_x005F_x000D_
8. Lu, C. et al. (2010) Molecular and cellular biology 30, 5432-43. PMID: 20837704 _x005F_x000D_ | ||||
| Примечание | For research use only |

Detects Matuzumab in indirect ELISA.




Свяжитесь с нами для индивидуальных предложений, оптовых запросов и других вопросов.
Почта: [email protected]


Быстрый доступ
Свяжитесь с нами
+86-027-65523339
Building C, No. 666, Shen Dun Si Lu, Wuhan, 430206, China
中文
English
한국어
日本語
Español
Français
Русский